These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies. Thiele J; Kvasnicka HM; Niederle N; Zirbes TK; Schmidt M; Dammasch J; Meuter BR; Leder LD; Kloke O; Diehl V Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders. Kvasnicka HM; Thiele J Histol Histopathol; 2004 Oct; 19(4):1245-60. PubMed ID: 15375769 [TBL] [Abstract][Full Text] [Related]
8. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Martyré MC Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621 [TBL] [Abstract][Full Text] [Related]
9. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading. Thiele J; Kvasnicka HM Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880 [TBL] [Abstract][Full Text] [Related]
10. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)--correlations between clinical and morphological features. Thiele J; Hoeppner B; Zankovich R; Fischer R Virchows Arch A Pathol Anat Histopathol; 1989; 415(3):191-202. PubMed ID: 2503923 [TBL] [Abstract][Full Text] [Related]
11. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification. Buhr T; Georgii A; Choritz H Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741 [TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor receptor β (PDGFRβ) immunohistochemistry highlights activated bone marrow stroma and is potentially predictive for fibrosis progression in prefibrotic myeloproliferative neoplasia. Méhes G; Tzankov A; Hebeda K; Anagnostopoulos I; Krenács L; Bedekovics J Histopathology; 2015 Nov; 67(5):617-24. PubMed ID: 25825163 [TBL] [Abstract][Full Text] [Related]
13. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis. Thiele J; Kvasnicka HM Ann Hematol; 2006 Apr; 85(4):226-32. PubMed ID: 16421727 [TBL] [Abstract][Full Text] [Related]
15. Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact. Thiele J; Kvasnicka HM; Werden C; Zankovich R; Diehl V; Fischer R Leuk Lymphoma; 1996 Jul; 22(3-4):303-17. PubMed ID: 8819080 [TBL] [Abstract][Full Text] [Related]
16. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis. Thiele J; Kvasnicka HM; Zankovich R; Diehl V Ann Hematol; 2001 Mar; 80(3):160-5. PubMed ID: 11320901 [TBL] [Abstract][Full Text] [Related]
17. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma. Dolgikh TY; Senchukova SR; Vinogradova EV; Krinitsyna YM Bull Exp Biol Med; 2020 Apr; 168(6):734-738. PubMed ID: 32333309 [TBL] [Abstract][Full Text] [Related]
18. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm]. Tovar-Bobadilla JL; Ortiz-Hidalgo C Gac Med Mex; 2016; 152(3):407-18. PubMed ID: 27335198 [TBL] [Abstract][Full Text] [Related]
19. Myelofibrosis in the myeloproliferative disorders. Ellis JT; Peterson P Prog Clin Biol Res; 1984; 154():19-42. PubMed ID: 6382293 [TBL] [Abstract][Full Text] [Related]
20. Proplatelet production and stromal fibrosis in myeloproliferative neoplasms. Wilkins BS Leuk Res; 2010 Nov; 34(11):1417-9. PubMed ID: 20701970 [No Abstract] [Full Text] [Related] [Next] [New Search]